What is the difference between Phase I and Phase III trials?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

What is the difference between Phase I and Phase III trials?

The main idea is how early safety and dosing studies compare with large-scale effectiveness testing. In early trials, the primary goal is to ensure the drug is safe and to figure out the right dose to use in humans, usually by studying healthy volunteers (and sometimes patients if there are safety concerns). These studies also give initial insight into how the drug is processed by the body. Later, Phase III trials enroll a large number of patients with the condition to determine whether the drug actually works in real-world use and to gather more information on safety in a broader population. This big, confirmatory testing helps establish true benefits, risks, and how the drug compares to existing treatments. So the correct answer reflects that Phase I focuses on safety and dosage with healthy volunteers, while Phase III assesses efficacy in large patient populations. The other statements mix up the typical roles: Phase II isn’t primarily about changing long-term safety or pharmacokinetics in that definitive way, Phase III isn’t conducted in healthy volunteers, and Drug pricing isn’t determined in these trials.

The main idea is how early safety and dosing studies compare with large-scale effectiveness testing. In early trials, the primary goal is to ensure the drug is safe and to figure out the right dose to use in humans, usually by studying healthy volunteers (and sometimes patients if there are safety concerns). These studies also give initial insight into how the drug is processed by the body. Later, Phase III trials enroll a large number of patients with the condition to determine whether the drug actually works in real-world use and to gather more information on safety in a broader population. This big, confirmatory testing helps establish true benefits, risks, and how the drug compares to existing treatments.

So the correct answer reflects that Phase I focuses on safety and dosage with healthy volunteers, while Phase III assesses efficacy in large patient populations. The other statements mix up the typical roles: Phase II isn’t primarily about changing long-term safety or pharmacokinetics in that definitive way, Phase III isn’t conducted in healthy volunteers, and Drug pricing isn’t determined in these trials.

More practice questions